The consultant episode: an unhelpful measure.

Docherty AJP, O'Connell J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Tibtech 1992;1O: 200-7. 2 Nagase H, Barratt AJ, Woessner JF Jr. Nomenclature and glossary of the matric metalloproteinases. Matrix 1992;1:421-4. 3 Hasty KA, Fourmotabbed TD, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, et al. Complete structure of the gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92 and 72 kilodalton enzyme genes in HT-1080 cells. J Biol Chem 1990;265: 11421-4. 4 Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene for 92 kDA type IV collagenase. Divergent regulation of expression for the 92 and 72 kilodalton enzyme genes in HT-1080 cells.J Biol Chem 1991;266:16485-90. 5 Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast cancer. Nature 1990;348:699-704. 6 Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1988;318:66-9. 7 Boone TC, Johnson MJ, DeClerck YA, Langley KE. cDNA closing and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 1990;87:2800-4. 8 Angel P, Imagaw M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, et al. Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor. Cell 1982;49:729-39. 9 Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJ. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinoma. Am J Med Sci 1991 ;302: 157-62. 10 Takemura M, Azuma C, Kimura T, Tokugawa Y, Miki M, Ono M, et al. Malignant cell-specific gelatinase activity in human endometrial carcinoma. Cancer 1992;70:147-51. 11 Campo E, Merino MJ, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA. Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. AmJ SurgPathol 1992;16:500-7. 12 Yoshida K, Tsujino T, Yasui W, Kameda T, Sano T, Nakayama H, et al. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28. Jpn J Cancer Res 1990;81:793-8. 13 Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Tumer DR. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J7 Cancer 1991;49:666-72. 14 Steams ME, Wang M. Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res 1991;51:5866-75. 15 D'Errico A, Garbisa S, Liotta LA, Castonovo V, Stetler-Stevenson WG, Grigioni WF. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 1991;4:239-46. 16 Momiki S, Baba M, Caamano J, Tizasa T, Nakajima M, Yamaguchi Y, et al. In vivo and in vitro invasiveness of human lung carcinoma cell lines. Invasion Metastasis 1991;11:66-75. 17 Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P. Detection of mRNA's encoding collagenase and stromelysin 2 in carcinomas of the head and neck. Invasion Metastasis 1991;11:76-83. 18 Cottam DW, Rennie IG, Woods K, Parson MA, Bunning RA, Rees RC. Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Invest Opthalmol Vis Sci 1922;33: 1923-7. 19 Akeli MG, Madoulet C, Rallet A, Jardillier JC. Inhibition of collagenolytic activity in human leukemic K562 cells by tamoxifen. Leuk Res 1991;15:1153-7. 20 Lu X, Levy M, Weinstein IB, Santella RM. Immunological quantitation of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 1991;51: 2138-43. 21 Ponton A, Coulombe B, Skup D. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 1991;51: 213843. 22 Melchiori A, Albini A, Ray JM, Stetler-Stevenson WG. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. CancerRes 1992;52:2353-6. 23 Khokka R, Waterhouse P, Lala P, Zimmer M, Denhardt DT. Increased proteinase expression during tumor progression of tissue inhibitor of metalloproteinases cell lines down-modulated for levels: a new transformation paradigm? J Cancer Res Clin Oncol 1991;117:333-8. 24 DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.